article thumbnail

Digital therapeutics startup Neuroglee raises $10M to help people with neurodegenerative conditions

TechCrunch

Neuroglee Therapeutics , a startup developing digital therapeutics for people with neurodegenerative diseases, has raised a $10 million Series A led by Openspace Ventures and EDBI. million to develop digital therapeutics for neurodegenerative diseases. Neuroglee gets $2.3 Venture investing in elder tech.

article thumbnail

BrainCheck brings in another $10M to detect, manage cognitive impairment

TechCrunch

BrainCheck , a Houston- and Austin-based company developing cognitive healthcare software to aid physicians in detecting and managing this type of care, raised $10 million in Series B funding to expand its R&D and go-to-market capabilities as it works on new digital therapeutics for Alzheimer’s and related dementias.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

This cardiac care startup just landed $20M for virtual rehab services

TechCrunch

Moving Analytics founders and undergraduate friends Harsh Vathsangam and Shuo Qiao met their third co-founder, Ade Adesanya, at the University of Southern California. Moving Analytics founders outside their Irvine office. Left to right: Joe Villanueva, Ade Adesanya, Harsh Vathsangam, Shuo Qiao. Image Credits: Moving Analytics.

health 92
article thumbnail

HealthTech Startup GOQii Bags US$50 Million Funding in Series C Round

AsiaTechDaily

It will also use the proceeds to expand in digital therapeutics, insurance, and international markets. About GOQii Founded in 2014 by Abhishek Sharma, Sachin Janghel, Champ Alreja, and Vishal Gondal, GOQii is a smart-tech-enabled healthcare platform that offers wearable fitness bands, diagnostics, and personal coaching.

article thumbnail

FDA: Orientation for Early Stage Startups

Y Combinator

One of the most common topics YC Bio founders ask us about is the US Food and Drug Administration (FDA), and the broader regulatory environment. But as a starting point, we wanted to touch on some of the most important concepts bio founders should think about. Emerging Therapeutic Areas. Conclusion.

startup 59